Buprenex Related Published Studies
Well-designed clinical trials related to Buprenex (Buprenorphine)
Neonatal outcomes and their relationship to maternal buprenorphine dose during
pregnancy. [2014]
A randomized, double-blind evaluation of buprenorphine taper duration in primary
prescription opioid abusers. [2013]
A randomised controlled trial of sublingual buprenorphine-naloxone film versus
tablets in the management of opioid dependence. [2013]
Cocaine use reduction with buprenorphine (CURB): rationale, design, and
methodology. [2013]
Analgesia after feline ovariohysterectomy under midazolam-medetomidine-ketamine
anaesthesia with buprenorphine or butorphanol, and carprofen or meloxicam: a
prospective, randomised clinical trial. [2012]
Effect of buprenorphine dose on treatment outcome. [2012]
Sublingual buprenorphine in acute pain management: a double-blind randomized
clinical trial. [2012]
Buprenorphine 5, 10 and 20 mug/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain. [2011.12.24]
Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system. [2011.12.15]
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. [2011.12]
Sublingual Buprenorphine in Acute Pain Management: A Double-Blind Randomized Clinical Trial. [2011.11.23]
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals. [2011.07.12]
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models. [2011.04]
Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films. [2011.03]
Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. [2011.03]
Fetal neurobehavioral effects of exposure to methadone or buprenorphine. [2011.03]
[The analgesic effect of plexus anesthesia with buprenorphine in patients]. [2011.02.01]
Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy. [2011.02.01]
Sedative and cardiopulmonary effects of buprenorphine and xylazine in horses. [2011.01]
A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts. [2011.01]
Two doses of dexmedetomidine in combination with buprenorphine for premedication in dogs; a comparison with acepromazine and buprenorphine. [2011.01]
The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone. [2011.01]
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic
moderate to severe low back pain: a randomized, double-blind study. [2011]
Induction of opioid-dependent individuals onto buprenorphine and
buprenorphine/naloxone soluble-films. [2011]
A comparison of acepromazine-buprenorphine and medetomidine-buprenorphine for preanesthetic medication of dogs. [2010.12.15]
Neonatal abstinence syndrome after methadone or buprenorphine exposure. [2010.12.09]
Buprenorphine enhances and prolongs the postoperative analgesic effect of bupivacaine in patients receiving infragluteal sciatic nerve block. [2010.12]
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. [2010.12]
A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: study feasibility and sample description. [2010.12]
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. [2010.10.13]
Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes. [2010.09]
Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial. [2010.09]
Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. [2010.09]
A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain. [2010.08]
Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. [2010.07]
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. [2010.07]
A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis. [2010.05]
Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. [2010.05]
Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. [2010.05]
Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial. [2010.05]
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. [2010.04]
Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. [2010.04]
A prospective multi-centre clinical trial to compare buprenorphine and butorphanol for postoperative analgesia in cats. [2010.04]
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. [2010.03.01]
Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets. [2010]
Buprenorphine transdermal system for opioid therapy in patients with chronic low
back pain. [2010]
Buprenorphine with bupivacaine for intraoral nerve blocks to provide postoperative analgesia in outpatients after minor oral surgery. [2009.12]
Subcutaneous pre-anaesthetic medication with acepromazine-buprenorphine is effective as and less painful than the intramuscular route. [2009.09]
A comparison of subarachnoid buprenorphine or xylazine as an adjunct to lidocaine for analgesia in goats. [2009.09]
Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine. [2009.08]
Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. [2009.08]
The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification. [2009.07.14]
[Prospective study on anesthesia for lumbar spine surgery--the effectiveness of the perioperative epidural anesthesia with buprenorphine] [2009.06]
Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. [2009.06]
Analgesia for cats after ovariohysterectomy with either buprenorphine or carprofen alone or in combination. [2009.03.21]
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery. [2009.03]
Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study. [2009.03]
Comparison of the analgesic properties of transdermally administered fentanyl and intramuscularly administered buprenorphine during and following experimental orthopedic surgery in sheep. [2009.03]
Treatment of ischemic pain in patients suffering from peripheral vasculopathy with transdermal buprenorphine plus epidural morphine with ropivacaine vs. epidural morphine with ropivacaine. [2009.03]
The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification. [2009.02.05]
Investigating medetomidine-buprenorphine as preanaesthetic medication in cats. [2009.02]
Buprenorphine tapering schedule and illicit opioid use. [2009.02]
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. [2009.01.01]
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. [2009.01.01]
A comparison of epidural buprenorphine plus detomidine with morphine plus detomidine in horses undergoing bilateral stifle arthroscopy. [2009.01]
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. [2008.12]
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. [2008.11.05]
Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. [2008.11]
[Topical application of morphine and buprenorphine gel has no effect in the sunburn model] [2008.10]
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. [2008.09]
Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. [2008.08]
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. [2008.08]
Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. [2008.07]
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. [2008.07]
Respiratory and cardiovascular effects of buprenorphine in conscious rabbits. [2008.07]
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. [2008.06.28]
Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs. [2008.06]
Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. [2008.05]
Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain. [2008.04.12]
Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial. [2008.04.01]
Buprenorphine injection to the stellate ganglion in the treatment of upper body chronic pain syndromes. [2008.04]
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. [2008.03]
Comparison between analgesic effects of buprenorphine, carprofen, and buprenorphine with carprofen for canine ovariohysterectomy. [2008.01]
Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects. [2008.01]
Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects. [2008.01]
QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial. [2007.12.10]
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. [2007.12.01]
A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. [2007.12]
Carprofen and buprenorphine prevent hyperalgesia in a model of inflammatory pain in cats. [2007.12]
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. [2007.10.08]
A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. [2007.09.03]
Effect of intra-articular administration of buprenorphine after arthrocentesis of the temporomandibular joint: a pilot study. [2007.09]
A comparison of tepoxalin-buprenorphine combination and buprenorphine for postoperative analgesia in dogs: a clinical study. [2007.09]
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. [2007.08]
Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. [2007.08]
Buprenorphine injection to the stellate ganglion in the treatment of upper body chronic pain syndromes. [2007.07.14]
Clinical pharmacology of buprenorphine in healthy, lactating goats. [2007.06]
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. [2007.05.01]
A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. [2007.05]
Assessment of buprenorphine, carprofen, and their combination for postoperative analgesia in olive baboons (Papio anubis). [2007.05]
Effects of buprenorphine on nociception and spontaneous locomotor activity in horses. [2007.03]
|
